6533b85cfe1ef96bd12bd62d
RESEARCH PRODUCT
Evaluation of the anaesthetic properties and tolerance of 1:100,000 articaine versus 1:100,000 lidocaine. : a comparative study in surgery of the lower third molar
María Martín-aresCristina Barona-doradoJosé M Martínez-gonzálezJorge Cortés-bretón-brinkmanNatalia Martínez-rodríguezsubject
MolarAdultMalemedicine.medical_specialtyLidocaineAdolescentAnesthesia DentalLidocaine HydrochlorideCarticaineArticaineArticaine HydrochlorideYoung AdultClinical and Experimental DentistrymedicineHumansSingle-Blind MethodAnesthetics LocalAdverse effectGeneral Dentistrybusiness.industryLidocaineMiddle Aged:CIENCIAS MÉDICAS [UNESCO]SurgeryEpinephrineOtorhinolaryngologyTolerabilityAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryResearch-ArticleFemaleMolar Thirdbusinessmedicine.drugdescription
Objectives: To evaluate the anaesthetic properties and tolerance of articaine versus lidocaine at equal vasoconstrictor concentration. Study Design: A total of 96 male and female patients who underwent surgical treatment of the lower third molar participated. Patients were randomly assigned to articaine hydrochloride with epinephrine 1:100,000 and lidocaine hydrochloride with epinephrine 1:100,000. The variables analysed were latency period, duration of anaesthetic effect, tolerance and adverse reactions. Results: Both the latency period and the duration of anaesthetic effect were greater for articaine, although the differences were not statistically significant. Latency: mean difference of 2.70 ± 2.12 minutes (95%CI of -1.51 minutes - 6.92 minutes). Duration: mean difference of -33 minutes 5 seconds ± 31 minutes (95% CI -1 hour 35 minutes - 29 minutes). There were 4 adverse events that did not require the patients to be withdrawn from the study. Conclusions: The anaesthetics in this study have very similar properties for use in surgery and have demonstrated a good safety and tolerability profile Key words: Articaine, lidocaine, vasoconstrictor, adverse reactions.
year | journal | country | edition | language |
---|---|---|---|---|
2011-12-01 |